News
Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, announced today that the company has closed a growth capital funding round of $168 million.
Before its two most recent rounds, Caris snagged $150 million in debt financing in October 2018 from Sixth Street, which also contributed an additional $75 million in debt financing to the 2020 round.
IRVING, Texas, April 7, 2025 /PRNewswire/ -- Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, announced today that the company has closed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results